Haemonetics to acquire OpSens for CAD $2.90/share in cash, expected close by March 31, 2024

HAEMONETICS CORP

Haemonetics (HAE) will pay CAD $2.90 per share for all OpSens common shares via a plan of arrangement under Québec law.
Closing conditions include 2/3 shareholder vote, HSR and Investment Canada approvals, court order, and no material adverse effect.
OpSens directors and officers owning ~4.75% of shares have agreed to vote in favor via voting agreements.
If OpSens terminates for a superior proposal or changes recommendation, it pays Haemonetics a CAD $12.075M termination fee.
The transaction must close by March 31, 2024, with an automatic 75-day extension if regulatory approvals are not yet obtained.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HAEMONETICS CORP entered into Arrangement Agreement with OpSens Inc., 9500-7704 Québec Inc. valued at CAD $2.90 (effective 2023-10-10).

Action: entry
Agreement: merger
Counterparty: OpSens Inc., 9500-7704 Québec Inc.
Value: CAD $2.90
Effective: 2023-10-10

Exact text from the filing

On October 10, 2023, Haemonetics Corporation, a Massachusetts corporation (“ Haemonetics ” or the “ Company ”), OpSens Inc., a corporation existing under the Business Corporations Act (Québec) (“ OpSens ”), and 9500-7704 Québec Inc., a corporation existing under the Business Corporations Act (Québec) and a wholly owned subsidiary of Haemonetics (the “ Purchaser ” and, together with Haemonetics, the “ Purchaser Parties ”), entered into an Arrangement Agreement (the “ Arrangement Agreement ”), pursuant to which, among other things, the Purchaser has agreed to acquire all of the issued and outstanding common shares of OpSens (the “ Arrangement ”).

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-23-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.